Analyzes biometric data (esp. blood glucose) for personalized health proposals (glucose flight)
| Date | Round | Amount |
|---|---|---|
| Sep 2024 | Seed THE PHAGE, a glucose-data-driven health startup, raised a pre-Series A led by Genesia Ventures with Vision Incubate, KSP, Meiji, TOPPAN, Mizuho Capital, Mirai Souzou Capital and Mediva, taking cumulative funding to 440M JPY. | $2.9M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.